-
2781
Development, validation and assessment of reproducibility of a modern version of semi-quantitative food frequency questionnaire for the adult population
Published 2022-03-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2782
Diagnostic and prognostic role of PAPP-A and inflammatory markers in various forms of coronary heart disease
Published 2010-06-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2783
Чазов Евгений Иванович
Published 2021-11-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2784
Position of 24-hour ambulatory blood pressure monitoring in modern practice
Published 2023-01-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2785
Metabolic (cytoprotective) therapy of menopausal disturbances
Published 2011-06-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2786
Restenosis risk factors after coronary stenting in metabolic syndrome patients
Published 2007-04-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2787
V INTERNATIONAL FORUM CARDIOLOGISTS AND THERAPISTS
Published 2015-12-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2788
ESSE-RF study: epidemiology and public health promotion
Published 2021-09-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2789
Losartan effectiveness in arterial hypertension patients (ELLA study)
Published 2007-04-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2790
OBSTRUCTIVE SLEEP APNEA AS CARDIOVASCULAR RISK FACTOR: TO TREAT OR NOT?
Published 2017-06-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2791
Intercommunication of blood group with cardiovascular disease risk factors
Published 2005-10-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2792
THE PREVALENCE OF RISK FACTORS FOR CHRONIC NON-COMMUNICABLE DISEASES IN STUDENT POPULATION
Published 2016-06-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2793
Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
Published 2010-04-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2794
Biobank data for studying the genetic architecture of osteoporosis and developing genetic risk scores
Published 2022-01-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2795
COMPARISON OF THE VALUE OF INFLAMMATION MARKERS AND HEART REMODELING PARAMETERS IN PATIENTS WITH DISTINCT TYPES OF ATRIAL FIBRILLATION
Published 2015-06-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2796
Comparability of cardiovascular risk assessment according to the SCORE and the coronary artery calcium score (Agatston score)
Published 2023-11-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2797
Statin safety: myths and reality
Published 2007-04-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2798
The possibilities of using antiplatelet agents during and after COVID-19 disease. Results of the Expert Council meeting
Published 2022-01-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2799
Prevalence of hypotension in populations of the Russian Federation and the United States of America according to 30-year follow-up
Published 2020-07-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article -
2800
ASSESSMENT OF TOTAL CARDIOVASCULAR RISK AS A PART OF REPEATED MEDICAL EXAMINATION OF EMPLOYEES OF A LARGE INDUSTRIAL ENTERPRISE
Published 2013-06-01“…Кардиоваскулярная терапия и профилактика…”
Get full text
Article